These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26649903)

  • 1. Soluble CXCL16 and risk of myocardial infarction: The HUNT study in Norway.
    Laugsand LE; Åsvold BO; Vatten LJ; Janszky I; Platou C; Michelsen AE; Arain F; Damås JK; Aukrust P; Ueland T
    Atherosclerosis; 2016 Jan; 244():188-94. PubMed ID: 26649903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM; Aukrust P; Ueland T; Smith C; Omland T; Hartford M; Caidahl K
    Circulation; 2009 Jun; 119(25):3181-8. PubMed ID: 19528340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXC chemokine ligand 16 as a prognostic marker in patients with intermediate coronary artery lesions: a 2-year follow-up study.
    Tan K; Lu S; Chen Y; Song X; Wu X; Jin Z; Yuan F; Zhou Y; Li H; Yang T; Zhou Y; Li Z; Chen F; Zhang S; Guo L; Wang W; Zhao Q; Huo Y; Yang X; Liu J; Chen B; Yan H; Li H; Ke Y; Chen K; Shi D
    Tohoku J Exp Med; 2011 Apr; 223(4):277-83. PubMed ID: 21467783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CXCL16 and long-term outcome in acute ischemic stroke.
    Ueland T; Smedbakken LM; Hallén J; Atar D; Januzzi JL; Halvorsen B; Jensen JK; Aukrust P
    Atherosclerosis; 2012 Jan; 220(1):244-9. PubMed ID: 22055341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of elevated serum CXCL16 and severity of acute coronary syndromes in male elders].
    Zhuge X; Wang LL; Sun N; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(46):3271-4. PubMed ID: 22333148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimarker risk assessment including osteoprotegerin and CXCL16 in acute coronary syndromes.
    Jansson AM; Hartford M; Omland T; Karlsson T; Lindmarker P; Herlitz J; Ueland T; Aukrust P; Caidahl K
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3041-9. PubMed ID: 23023373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix markers and risk of myocardial infarction: The HUNT Study in Norway.
    Ueland T; Laugsand LE; Vatten LJ; Janszky I; Platou C; Michelsen AE; Damås JK; Aukrust P; Åsvold BO
    Eur J Prev Cardiol; 2017 Jul; 24(11):1161-1167. PubMed ID: 28429960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased plasma CXCL16/SR-PSOX concentration is associated with coronary artery disease.
    Sheikine Y; Bang CS; Nilsson L; Samnegård A; Hamsten A; Jonasson L; Eriksson P; Sirsjö A
    Atherosclerosis; 2006 Oct; 188(2):462-6. PubMed ID: 16378611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary inflammatory index and risk of first myocardial infarction; a prospective population-based study.
    Bodén S; Wennberg M; Van Guelpen B; Johansson I; Lindahl B; Andersson J; Shivappa N; Hebert JR; Nilsson LM
    Nutr J; 2017 Apr; 16(1):21. PubMed ID: 28376792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating soluble SR-PSOX/CXCL16 as a biomarker for acute coronary syndrome -comparison with high-sensitivity C-reactive protein.
    Mitsuoka H; Toyohara M; Kume N; Hayashida K; Jinnai T; Tanaka M; Kita T
    J Atheroscler Thromb; 2009 Oct; 16(5):586-93. PubMed ID: 19729872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans.
    Lehrke M; Millington SC; Lefterova M; Cumaranatunge RG; Szapary P; Wilensky R; Rader DJ; Lazar MA; Reilly MP
    J Am Coll Cardiol; 2007 Jan; 49(4):442-9. PubMed ID: 17258089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of transmembrane and soluble CXCL16 and the relation with interferon-alpha secretion in patients with Behçet's disease.
    Yilmaz S; Cinar M; Pekel A; Simsek I; Musabak U; Erdem H; Pay S
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):84-7. PubMed ID: 24064021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte/macrophage and T cell activation markers are not independently associated with MI risk in healthy individuals - results from the HUNT Study.
    Ueland T; Laugsand LE; Vatten LJ; Janszky I; Platou C; Michelsen AE; Damås JK; Aukrust P; Åsvold BO
    Int J Cardiol; 2017 Sep; 243():502-504. PubMed ID: 28615143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum CXCL16 as a novel marker of renal injury in type 2 diabetes mellitus.
    Zhao L; Wu F; Jin L; Lu T; Yang L; Pan X; Shao C; Li X; Lin Z
    PLoS One; 2014; 9(1):e87786. PubMed ID: 24489966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum CXCL16 as a Novel Biomarker of Coronary Artery Disease in Type 2 Diabetes Mellitus: a Pilot Study.
    Zhou F; Wang J; Wang K; Zhu X; Pang R; Li X; Zhu G; Pan X
    Ann Clin Lab Sci; 2016; 46(2):184-9. PubMed ID: 27098626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma adiponectin levels and risk of myocardial infarction in men.
    Pischon T; Girman CJ; Hotamisligil GS; Rifai N; Hu FB; Rimm EB
    JAMA; 2004 Apr; 291(14):1730-7. PubMed ID: 15082700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifelong Gender Gap in Risk of Incident Myocardial Infarction: The Tromsø Study.
    Albrektsen G; Heuch I; Løchen ML; Thelle DS; Wilsgaard T; Njølstad I; Bønaa KH
    JAMA Intern Med; 2016 Nov; 176(11):1673-1679. PubMed ID: 27617629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine SR-PSOX/CXCL16 expression in peripheral blood of patients with acute coronary syndrome.
    Yang HL; Xu YY; DU LF; Liu CH; Zhao Q; Wei WJ; You Y; Quan ZH
    Chin Med J (Engl); 2008 Jan; 121(2):112-7. PubMed ID: 18272035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-fasting triglycerides predict incident acute myocardial infarction among those with favourable HDL-cholesterol: Cohort Norway.
    Egeland GM; Igland J; Sulo G; Nygård O; Ebbing M; Tell GS
    Eur J Prev Cardiol; 2015 Jul; 22(7):872-81. PubMed ID: 24817696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.